32
Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to Reproductive Health Research William A. Fisher, Ph.D Department of Psychology Department of Obstetrics and Gynaecology University of Western Ontario London Ontario Canada Center for Health Intervention and Prevention University of Connecticut Storrs Connecticut USA

Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to Reproductive Health Research William A. Fisher, Ph.D Department

Embed Size (px)

Citation preview

Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary

Approaches to Reproductive Health Research

William A. Fisher, Ph.DDepartment of Psychology

Department of Obstetrics and GynaecologyUniversity of Western Ontario

London Ontario Canada

Center for Health Intervention and PreventionUniversity of ConnecticutStorrs Connecticut USA

Monodisciplinary, Multidisciplinary, Interdisciplinary, and Transdisciplinary Approaches to

Reproductive Health Research

• Objectives– Define monodisciplinary, multidisciplinary,

interdisciplinary, and transdisciplinary approaches.

– Provide examples of transdisciplinary approaches.

– Discuss transdisciplinary research team creation and functioning.

Science = Explanation

• The only reason to do something in scientific research is to increase our:– Understanding– Prediction– Control

Monodisciplinary Approaches

• Exploiting the knowledge base, research methodology, and research personnel of a single established scientific discipline.

• Traditional research paradigm.

Monodisciplinary Approaches

• Advantages: cumulative disciplinary knowledge base, mature disciplinary research methodology, availability of experienced research personnel, homogeneous research culture.

• Disadvantages: narrow focus on restricted dimensions of potentially complex and multilevel reproductive health research questions; lack of comprehensive scope to provide complete understanding of reproductive health research problem.

Multidisciplinary Approaches

• Multidisciplinary research involves scientists from different disciplines who work independently and in parallel on different and separate aspects of a reproductive health research question.

• For example, stem cell researcher and an ethicist form a multidisciplinary team to study stem cell issues and publish papers on different aspects of this topic in special issue of a journal.

– After Sorrels-Jones, 1997

Multidisciplinary Approaches• Advantages: more comprehensive

understanding of a reproductive health research question may accumulate; no research approach, knowledge base, or research culture heterogeneity to challenge researchers.

• Disadvantage: “Discoordiante parallel play” fails to exploit and integrate scientific viewpoints and expertise of multiple disciplines; gains in comprehensiveness somewhat random and at best additive.

Interdisciplinary Approaches

• “Interdisciplinary research is a cooperative effort by a team of investigators, each expert in the use of different methods and concepts, who have joined in an organized program to attack a challenging problem. Ongoing communication and reexamination of postulates among team members promote broadening of concepts and enrichment of understanding. Although each member is primarily responsible for the efforts in his or her own discipline, all share responsibility for the final product.”

– Institute of Medicine, 2002

Interdisciplinary Approaches

• Advantages: Exploits an array of relevant disciplinary knowledge bases, methodologies, and perspectives to gain comprehensive understanding of complex and multilevel reproductive health research problem.

• Disadvantages: Leaves unanswered the question of how the multiple relevant disciplinary aspects of the reproductive health research question will be identified and how the interdisciplinary contributions will be reassembled to represent a complex understanding of the reproductive health problem.

Interdisciplinary Approaches

• Close, But No Cigar…

Transdisciplinary Approach

• Transdisciplinary research involves active and collaborative analysis of a reproductive health research question to:– identify its potentially multiple relevant disciplinary

dimensions; – identify the interdisciplinary team needed to address the

problem;– construct a working model of the multiple determinants

and consequences of a reproductive health condition or treatment

• Transdisciplinary research incorporates and goes beyond interdisciplinary approach.

Transdisciplinary Approach to Reproductive Health Research

Reproductive Health Research

Question“Before”

Transdisciplinary Analysis

--What are the significant biological, behavioral, social, economic, ethical, and legal dimensions of the research problem?

--What are the disciplines, conceptual models, research methodologies that must be recruited to comprehensively address the problem?

What is the transdiciplinary working model?Results in “Interdisciplinarity Done Well”

Transdiscipliary Analysis

Reproductive Health

Research Question

“After”

Transdisciplinary Approach

• Advantages: actively identifies a working conceptual model incorporating multiple relevant determinants of reproductive health phenomena and multiple relevant outcomes of reproductive health interventions.

• Advantage: Provides comprehensive understanding of reproductive health research question.

Transdisciplinary Approach

• Disadvantage: Requires understanding of multiple disciplinary knowledge bases, methodologies, approaches, and research perspectives and cultures.

• Disadvantage: Requires commitment to the idea that transdisciplinary approach, where appropriate, may comprise superior science.

• Disadvantage: No one, within graduate school or residency, is trained to do transdiciplinary research.

Transdisciplinary Approach to Research on Erectile Dysfunction:

UrologyPharmacology

Molecular BiologyPsychology

Sexual Ecology

Biology of Biology of Erectile DysfunctionErectile Dysfunction

Drug ActionDrug Action

PatientPatient

PartnerPartnerSexual Sexual

IntimacyIntimacy

RelationshipRelationship

Biology:ED Prevalence Increases with Age

811

15

22

30

37

0

5

10

15

20

25

30

35

40

20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 75

Pre

vale

nce

of

self

-rep

ort

ed E

D (

%)

Rosen et al, Curr Med Res Opin. 2004;20:607-617.

10

1519

31

42

0

5

10

15

20

25

30

35

40

45

No disease ^Chol ^Chol + HTN CHD CHD +Diabetes

Men

rep

ort

ing

co

nd

itio

n (

%)

Biology:ED Prevalence Increases with Comorbid Conditions

Sand M et al. ISSIR 2002

Biology:PDE5 Inhibitor Pharmacokinetic Parameters

1 Klotz et al, Pharmacotherapy, 2002, 22:418. 2 Sildenafil product monograph. 3 Porst, IJIR, 2002, 14 (Suppl 1): S57-S64.

Data derived from separate studies, values shown as means

Vardenafil 1 Sildenafil 2 Tadalafil 3

20 mg 100 mg 20 mg

0.8 1.16 2.0

4.7 3.82 17.5

31.8 327 378

tmax, h

t 1/2, h

C max,g/l

AUC, g.h/l 96.3 196 3 806 6

ITT population

21 2028

65

30

71

30

73

28

68

26

69

0

20

40

60

80

100 Placebo Vardenafil

n = 111 113 111 112 105 104 95 103 111 113 110 111

*p<0.0001 (ANCOVA)

LS

mea

n p

er-p

atie

nt

succ

ess

rate

(%

)

* * * *

Biology: PDE5i Induced Maintenance of Erection to Completion of Intercourse

*

Baseline Week 4 Week 8 Week 12 Overall(0-12 wks)

LOCF

But…Effective Drug that is Rarely Used:Cascade of ED Treatment Seeking

58

41

37

29

22

16

0 10 20 30 40 50 60 70

Spoke with doctor re ED

Spoke with doctor re PDE5

Tried PDE5 at least once

Received PDE5 Rx

Used more than once

Still using

Percentage of men

N = 2,912Men who self-reported ED

Rosen et al, Curr Med Res Opin. 2004;20:607-617.

Severity of Dysfunction

Attitudes, Beliefs,

Relationship

Drug Action

Treatment Seeking

Did Nothing…Spoke with MD…

Currently Using PDE5…

Sexual Ecology:Understanding ED Treatment Seeking:Severity, Attitudes, and Drug Action

Sexual Ecology:Attitudes, Beliefs, Severity of Dysfunction, and ED Treatment Seeking

► Medicine for erections is a dangerous thing

► Erection problem would go away with healthier lifestyle

► Erection problem makes me feel less confident► Erection problem due to getting older

► Impossible to speak face to face about erections

► Afraid of losing partner because of problem

Fisher W et al. 2nd ICESD, Paris 2003, Poster Nr. 101

1.22

0.79

1.42

1.33

0.71

0.428

0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 1.2 1.3 1.4 1.5

Odds Ratio

Less likely to seek treatment

More likely to seek treatment

3.5

3.5

p < 0.05

► Severity (severe vs mild)

Sexual Ecology: Drug Action and Discontinuation of PDE5 Inhibitor Therapy

19

22

29

34

34

0 10 20 30 40

Side effects

Worked Occasionally

Too Expensive

Did not work at all

Erection not Hard enough

% of men

n=255

Eardley, I et al. Eur. Urol 2003; Suppl 2(1):97

Sexual Ecology: Physician Inaction and Failure to Treat

An overwhelming majority of physicians are comfortable talking about ED, but very few raise the subject with their patients…

22

69

72

92

16

75

77

95

0 20 40 60 80 100

ED brought up by physician

Satisfied they have enoughtime to reach an ED diagnosis

Agreement most men haveED occasionally

Comfortable talking withpatients about ED

GPs (n = 168) Urologists (n = 174)

Percentage responding

Fisher W et al. J Men’s Health Gend (in press)

52

11

6

11

9

5

5

0 10 20 30 40 50 60

Never know/unexpected

<1/2hr

About 1/2hr

About 1hr

2-3hrs

4-11hrs

>12hrs in advance

Sexual Ecology:Drug Action Lack of Fit with Sexual RelationshipHow far in advance do you usually know you will have sexual activity?

Respondents (%)

Rosen et al, Curr Med Res Opin 2004;20:607-617

Sexual Ecology

Biology of Biology of Erectile DysfunctionErectile Dysfunction

Drug ActionDrug Action

PatientPatient

PartnerPartnerSexual Sexual

IntimacyIntimacy

RelationshipRelationship

n=229 (randomized)

4 wk run-inunmedicated

Week -4 0 4 8 12

Placebo

Placebo 5/10/20 mg

Vardenafil 10 mgVardenafil 5/10/20

mg

V1 V2 V3V4 V5

Placebo 5/10/20 mg

Vardenafil 5/10/20 mg

Partner Satisfaction Study Design

• Double-blind, 25-center, flexible-dose, parallel arms

• Men with ED for 6 months

• Female partners motivated to pursue treatment for their male partner’s ED

• Modified Sexual Life Quality Questionnaire (mSLQQ)

• Treatment Satisfaction Scale (TSS)

2623

30

66

28

64

0

20

40

60

80

100

Partner Satisfaction and SQLmSLQQ – QoL domain (score 0–100)

26 2833

67

32

66

0

20

40

60

80

100

n = 111 110 104 97 111 110 Baseline Week 12 LOCF (mean)

* p < 0.001(ANCOVA)

n = 108 106 102 95 108 106 Baseline Week 12 LOCF (mean)

Male subjects Female partners

Same asprior to ED

worse

better

Levitra®Placebo

LS

mea

n s

core * * * *

ITT populationFisher W et al. J Sex Med 2005; 2:699-708

64 64 63 64 6464 65 6360 58

0

20

40

60

80

Frequencyof sex

Durationof sex

Ease ofinsertion

Ease of achievingorgasm

Anxietyabout

performance

n = 108 111 108 111 108 111 108 111 108 111

Lea

st s

qu

ares

mea

n s

core

Female Baseline Male Baseline

BL LS mean

LS mean

201914

1924

33

27

19 2528

Partner Satisfaction and SQL mSLQQ Domains—Subjects and Partners

Fisher W et al. J Sex Med 2005; 2:699-708

Female Outcome Male Outcome

6872

66 686566 67 65 66 67

0

20

40

60

80

Pleasureof anticipation

Carefreefeelings

Pleasureorgasm

Pleasureoverall

Partner pleasureoverall

n = 107 111 108 111 108 111 108 111 108 111

Lea

st s

qu

ares

mea

n s

core

BL LS mean

LS mean

272426283031 29

3130

23

Partner Satisfaction and SQL mSLQQ Domains–Subjects/Partners

Fisher W et al. J Sex Med 2005; 2:699-708

Female Baseline Male BaselineFemale Outcome Male Outcome

0

20

40

60

80

100

n = 87 98 98 104

Week 12 LOCF

SLQQ-QoL score < 50 at baseline; 50 at double blind endpoint

71

16

69

15

Co

up

les

(%)

Partner Satisfaction StudyQuality of life – both partners return to

pre-ED levelsLevitra®Placebo

Fisher, et al J Sex Med 2005; 2:675-684